GlaxoSmithKline Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 8,712.2 million compared to INR 7,950.9 million a year ago. Net income was INR 1,565.1 million compared to net loss of INR 6,611.6 million a year ago. Basic earnings per share from continuing operations was INR 9.24 compared to basic loss per share from continuing operations of INR 39.03 a year ago. For the nine months, total revenue was INR 24,660.9 million compared to INR 25,117.7 million a year ago. Net income was INR 3,438.2 million compared to net loss of INR 448.7 million a year ago. Basic earnings per share from continuing operations was INR 20.3 compared to basic loss per share from continuing operations of INR 2.65 a year ago.